ARS Pharmaceuticals (SPRY) P/E ratio

PE ratio:

N/A
June 27, 2025

Summary

  • SPRY price to earnings ratio is not available.

Performance

SPRY PE ratio Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Range

OtherSPRYvaluation metrics

PE ratio Formula

P/E =  
Price
TTM Earnings Per Share

SPRY PE ratio Trends

PeriodPeriodPE ratioPE ratioPricePriceTTM EPSTTM EPSTTM revenueTTM revenue
todaytoday-+0.7%-342.9%+8.9%
1 m1 month-+24.5%--
3 m3 months-+44.1%-342.9%+8.9%
6 m6 months-+68.7%--
ytdytd-+72.5%--
1 y1 year-+126.1%+67.3%-
5 y5 years----

SPRY PE ratio Highs & Lows

PeriodPeriodHighHighCurrent vs highvs highLowLowCurrent vs lowvs low
1 m1-month
3 m3-month180.43178.43
6 m6-month212.86142.71
1 y1-year212.86142.71
3 y3-year212.86142.71
5 y5-year212.86142.71
alltimeall time212.86142.71

SPRY PE ratio History

DateValue
DateValue
2024
153.71

FAQ

  • What is the all time high PE ratio for ARS Pharmaceuticals?

What is the all time high PE ratio for ARS Pharmaceuticals?

ARS Pharmaceuticals all-time high price to earnings ratio is 212.86
On this page